DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 52.06 1.29%
S&P 500 1,862.31 19.33 1.05%
market minute promo

Novavax, Inc.

NASDAQ: NVAX

4.05 0.36 (9.76%)

REAL-TIME: Last trade at

Extended Hours: $4.05 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

NVAX $4.05 9.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.74
Previous Close $3.69
Daily Range $3.74 - $4.06
52-Week Range $1.68 - $6.95
Market Cap $846.7M
P/E Ratio -11.90
Dividend (Yield) $0.00 (0.0%)
Volume 3,641,728
Average Daily Volume 5,302,454
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary Rss Feed

Are Inovio and Rockwell Medical In for a Bad Year?

These biopharmas have started the year poorly and could be in for a bad 2014.

Novavax: Promising Pipeline And Stable Revenue Add To Upside

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Insiders And Analysts Like These Speculative Small Cap Stocks

5 Stocks With Big Insider Buying

Insider Trading Alert - UNP, OPK And NVAX Traded By Insiders

Novavax Is Now Oversold (NVAX)

Benzinga's Top #PreMarket Gainers

Novavax's CEO Discusses Q4 2013 Results - Earnings Call Transcript

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POW

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POWR, CISG, MED, PLOW

Earnings Expectations For The Week Of March 10: The Season Winds Down

See More NVAX News...

NVAX's Top Competitors

NVAX $4.05 (9.76%)
Current stock: NVAX
AMGN $115.54 (0.47%)
Current stock: AMGN
GILD $69.28 (1.63%)
Current stock: GILD
BIIB $291.48 (2.10%)
Current stock: BIIB